CHICAGO--(BUSINESS WIRE)--Health care professionals, patients and payors are increasingly seeking safe first-line therapeutic alternatives that provide demonstrated efficacy without drug-related side effects. Neurowave Medical Technologies™ (NMT), a leading neuroscience company that develops and commercializes drug-free, non-invasive transdermal devices based on a patented and proprietary neuromodulation therapeutic technology platform, today announced an expanded focus of its corporate direction, which will broaden its market and growth potential.
